Camlin Fine Sciences Reports Narrowed Q1 Loss Despite Revenue Dip Aug 08, 2025
Camlin Fine Sciences Reports Improved Q4 EBITDA and Margin, Narrows Losses May 23, 2025
More news about Camlin Fine Sciences
27Feb 25
Camlin Fine Sciences to Expand Portfolio with Majority Stake Acquisition in Vinpai
Camlin Fine Sciences Ltd (CFSL) plans to acquire a majority stake in Vinpai through a share swap arrangement. The deal values Vinpai shares at €3.60 each. This strategic move aims to expand CFSL's product portfolio and market reach in the specialty chemicals industry. The acquisition is expected to bring portfolio expansion, increased market reach, potential synergies, and enhanced innovation capabilities for CFSL.
25Feb 25
Camlin Fine Sciences to Acquire Up to 100% Stake in French Ingredient-Tech Company Vinpai S.A.
Camlin Fine Sciences Limited (CFS) plans to acquire up to 100% stake in Vinpai S.A., a French ingredient-tech company specializing in natural alternatives to chemical additives. The acquisition involves a multi-step process including a share purchase agreement for a 78.68% stake, a €3.3 million convertible bond investment, and a potential mandatory tender offer for remaining shares. The total acquisition cost could reach €5.96 million. This strategic move aims to expand CFS's product portfolio, access new technologies, and strengthen its position in the food, cosmetics, and nutraceutical industries. Vinpai, founded in 2011, has shown consistent growth with a projected turnover of €9.2 million in 2024.